| Date | Time | Source | Headline | Symbol | Company |
| 09/02/2018 | 14:13 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 07/11/2017 | 11:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 07/11/2017 | 11:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 07/11/2017 | 11:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 07/11/2017 | 11:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 07/11/2017 | 11:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 07/11/2017 | 11:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 07/11/2017 | 11:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 07/11/2017 | 11:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 07/11/2017 | 11:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 07/11/2017 | 11:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 19:27 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 19:26 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 19:25 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 19:25 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 19:25 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 19:25 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 19:25 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 19:25 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 19:25 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 19:24 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 19:24 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 19:24 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 19:24 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 19:23 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 19:22 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 19:22 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 17:20 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 17:20 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 31/10/2017 | 17:20 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |